Novel Lycorine Derivatives as Anticancer Agents: Synthesis and In Vitro Biological Evaluation

Lycorine, which is the most abundant alkaloid isolated from the Amaryllidaceae family of plants, reportedly exhibits promising anticancer activities. Herein, a series of novel lycorine derivatives were synthesized and evaluated for their in vitro inhibitory activities against seven different cancer cell lines, including A549, HCT116, SK-OV-3, NCI-H460, K562, MCF-7 and HL-60. The results indicated that compounds bearing diverse amine substituents at the C-2 position demonstrated good anticancer activities. The selectivity towards different cancer cell lines of the synthesized derivatives is discussed.

[1]  R. Kiss,et al.  C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells. , 2014, Bioorganic & medicinal chemistry letters.

[2]  Ambily Nath Indu Viswanath,et al.  Resistance by allostery: a novel perspective for eg5-targeted drug design. , 2013, Journal of medicinal chemistry.

[3]  S. Patil.  A RECENT REVIEW ON ANTICANCER HERBAL DRUGS , 2013 .

[4]  Ping Yang,et al.  Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. , 2013, Toxicology letters.

[5]  Mao Ye,et al.  Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition , 2012, Cancer Cell International.

[6]  Ping Yang,et al.  Lycorine hydrochloride inhibits metastatic melanoma cell‐dominant vasculogenic mimicry , 2012, Pigment cell & melanoma research.

[7]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[8]  R. Kiss,et al.  In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives. , 2011, Bioorganic & medicinal chemistry.

[9]  Shi-Biao Wu,et al.  Triterpenoids and steroids from the fruits of Melia toosendan and their cytotoxic effects on two human cancer cell lines. , 2010, Journal of natural products.

[10]  R. Kiss,et al.  Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. , 2009, Journal of medicinal chemistry.

[11]  Shi-Biao Wu,et al.  Antiproliferative and Apoptotic Activities of Linear Furocoumarins from Notopterygium incisum on Cancer Cell Lines , 2009, Planta medica.

[12]  J. McNulty,et al.  Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells , 2009, Phytochemistry.

[13]  X. Jiao,et al.  Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. , 2009, Cancer letters.

[14]  A. Kornienko,et al.  Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives , 2009, Phytochemistry Reviews.

[15]  A. Kornienko,et al.  Chemistry, biology, and medicinal potential of narciclasine and its congeners. , 2008, Chemical reviews.

[16]  L. Angenot,et al.  In Vitro cytotoxicity of some medicinal plants from Georgian Amaryllidaceae , 2007, Phytotherapy research : PTR.

[17]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[18]  Jing Liu,et al.  Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. , 2007, Oncology reports.

[19]  Mao Ye,et al.  Effects of lycorine on HL‐60 cells via arresting cell cycle and inducing apoptosis , 2004, FEBS letters.

[20]  C. Codina,et al.  Bioactive alkaloids from Brunsvigia radulosa. , 2000, Phytochemistry.

[21]  W. Wildman,et al.  Alkaloid biosynthesis and interconversions. The conversion of caranine to lycorine. , 1967, Journal of the American Chemical Society.